Alan Keller to Treatment Outcome
This is a "connection" page, showing publications Alan Keller has written about Treatment Outcome.
Connection Strength
0.027
-
Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. J Clin Oncol. 2010 Apr 10; 28(11):1835-42.
Score: 0.014
-
Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol. 2009 Apr 20; 27(12):1941-7.
Score: 0.013